Guidance: Cervical screening: programme and colposcopy management

Nhs England

September 27

08:30 2024

This document gives guidance for commissioners, screening providers and programme managers working in and with the NHS Cervical Screening Programme.

It provides information on:

policy
management and referral guidelines for colposcopy
providing a quality colposcopy clinic (quality standards)
colposcopic diagnosis, treatment and follow up
management of cases relating to pregnancy, menopause, contraception and hysterectomy
screening and management of immunosuppressed individuals
job roles (lead clinician colposcopist and lead colposcopy nurse)
screening and colposcopy pathways (flowcharts)

This publication was previously published by Public Health England, which closed on 30 September 2021.

Published 3 May 2010
Last updated 27 September 2024 +show all updates

27 September 2024
In the details, changed 'originally published by Public Health England' to 'previously published by Public Health England'.
26 September 2024
Added clarification that publication was originally published by Public Health England.
25 September 2024
Change note 1: Clarified that the discussion of moderate referrals with CIN1 at the MDT was discretionary and there was no requirement to do so. Change note 2: Clarified that cytology should be reviewed prior to MDT in cases of conservative management of CIN2.
5 January 2023
4.6 change to first line.
28 September 2021
Minor text changes to chapter 3 (section 5.2). More information added to chapter 4 about management of incompletely excised CGIN (section 3.3), follow up of stage Ia1 (section 4.4) and individuals referred with low-grade cytology (section 4.6).
5 February 2020
Updated guidance in line with the introduction of primary human papillomavirus (HPV) screening in England.
14 March 2016
Published 3rd edition of guidance.
3 May 2010
First published.

We don't have any comments for this article yet. Why not join in and start a discussion.